Defining the stoichiometry of inositol 1,4,5-trisphosphate binding required to initiate Ca2+ release

Science Signaling

Volumn 9, Issue 422, 2016, Pages

  Alzayady, Kamil J ^a   Wang, Liwei ^a   Chandrasekhar, Rahul ^a   Wagner, Larry E ^a   Van Petegem, Filip ^b   Yule, David I ^a  

^a UNIVERSITY OF ROCHESTER   (United States)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

B LYMPHOCYTE RECEPTOR; CALCIUM ION; COMPLEMENTARY DNA; DIMER; INOSITOL 1,4,5 TRISPHOSPHATASE; LIGAND; MONOMER; CALCIUM; INOSITOL 1,4,5 TRISPHOSPHATE; INOSITOL 1,4,5 TRISPHOSPHATE RECEPTOR; ITPR1 PROTEIN, HUMAN; PROTEIN BINDING; PROTEIN SUBUNIT;

ARTICLE; CALCIUM TRANSPORT; CRISPR CAS SYSTEM; HEK293 CELL LINE; HUMAN; HUMAN CELL; HYDROGEN BOND; IMMUNOCOMPETENT CELL; LIGAND BINDING; MOLECULAR INTERACTION; MUTAGENESIS; PRIORITY JOURNAL; STOICHIOMETRY; WILD TYPE; ANIMAL; BINDING SITE; CALCIUM SIGNALING; CELL LINE; CHEMICAL STRUCTURE; CHEMISTRY; GENETICS; METABOLISM; MOLECULAR MODEL; MUTATION; PROTEIN DOMAIN; PROTEIN MULTIMERIZATION; PROTEIN SUBUNIT;

ANIMALS; BINDING SITES; CALCIUM; CALCIUM SIGNALING; CELL LINE; CRISPR-CAS SYSTEMS; HEK293 CELLS; HUMANS; INOSITOL 1,4,5-TRISPHOSPHATE; INOSITOL 1,4,5-TRISPHOSPHATE RECEPTORS; MODELS, MOLECULAR; MOLECULAR STRUCTURE; MUTATION; PROTEIN BINDING; PROTEIN DOMAINS; PROTEIN MULTIMERIZATION; PROTEIN SUBUNITS;

EID: 84963533462     PISSN: 19450877     EISSN: 19379145     Source Type: Journal    
DOI: 10.1126/scisignal.aad6281     Document Type: Article

References (42)

1. M. J. Berridge, P. Lipp, M. D. Bootman, The versatility and universality of calcium signalling. Nat. Rev. Mol. Cell Biol. 1, 11-21 (2000).
2. 2+ release channel orthologs. Mol. Biol. Evol. 32, 2236-2253 (2015).
3. 2+ release channels. Physiol. Rev. 87, 593-658 (2007).
4. C.W. Taylor, A. A. Genazzani, S. A. Morris, Expression of inositol trisphosphate receptors. Cell Calcium 26, 237-251 (1999).
5. I. Bezprozvanny, The inositol 1,4,5-trisphosphate receptors. Cell Calcium 38, 261-272 (2005).
6. K. Uchida, H. Miyauchi, T. Furuichi, T. Michikawa, K. Mikoshiba, Critical regions for activation gating of the inositol 1,4,5-trisphosphate receptor. J. Biol. Chem. 278, 16551-16560 (2003).
7. D. I. Yule, M. J. Betzenhauser, S. K. Joseph, Linking structure to function: Recent lessons from inositol 1,4,5-trisphosphate receptor mutagenesis. Cell Calcium 47, 469-479 (2010).
8. H. Yamazaki, J. Chan, M. Ikura, T. Michikawa, K. Mikoshiba, Tyr-167/Trp-168 in type 1/3 inositol 1,4,5-trisphosphate receptor mediates functional coupling between ligand binding and channel opening. J. Biol. Chem. 285, 36081-36091 (2010).
9. 3 and ryanodine receptors. Nature 483, 108-112 (2012).
10. D. Boehning, S. K. Joseph, Direct association of ligand-binding and pore domains in homo- and heterotetrameric inositol 1,4,5-trisphosphate receptors. EMBO J. 19, 5450-5459 (2000).
11. 3R channels revealed by electron cryomicroscopy. Nature 527, 336-341 (2015).
12. 3 receptors: Toward understanding their activation. Cold Spring Harb. Perspect. Biol. 2, a004010 (2010).
13. 3 receptor. Curr. Top. Membr. 66, 171-189 (2010).
14. I. Bezprozvanny, Role of inositol 1,4,5-trisphosphate receptors in pathogenesis of Huntington's disease and spinocerebellar ataxias. Neurochem. Res. 36, 1186-1197 (2011).
15. 3R2 function inhibits sweat secretion in both humans and mice. J. Clin. Invest. 124, 4773-4780 (2014).
16. 2+ release channels in neurological diseases. Pflugers Arch. 460, 481-494 (2010).
17. L. Huang, J. W. Chardon, M. T. Carter, K. L. Friend, T. E. Dudding, J. Schwartzentruber, R. Zou, P. W. Schofield, S. Douglas, D. E. Bulman, K. M. Boycott, Missense mutations in ITPR1 cause autosomal dominant congenital nonprogressive spinocerebellar ataxia. Orphanet J. Rare Dis. 7, 67 (2012).
18. M. Iwai, Y. Tateishi, M. Hattori, A. Mizutani, T. Nakamura, A. Futatsugi, T. Inoue, T. Furuichi, T. Michikawa, K. Mikoshiba, Molecular cloning of mouse type 2 and type 3 inositol 1,4,5-trisphosphate receptors and identification of a novel type 2 receptor splice variant. J. Biol. Chem. 280, 10305-10317 (2005).
19. M. Iwai, T. Michikawa, I. Bosanac, M. Ikura, K. Mikoshiba, Molecular basis of the isoformspecific ligand-binding affinity of inositol 1,4,5-trisphosphate receptors. J. Biol. Chem. 282, 12755-12764 (2007).
20. 2+ safeguards against spontaneous activity. Curr. Biol. 7, 510-518 (1997).
21. T. Meyer, D. Holowka, L. Stryer, Highly cooperative opening of calcium channels by inositol 1,4,5-trisphosphate. Science 240, 653-656 (1988).
22. 2+. Cell Calcium 32, 321-334 (2002).
23. J.-F. Dufour, I. M. Arias, T. J. Turner, Inositol 1,4,5-trisphosphate and calcium regulate the calcium channel function of the hepatic inositol 1,4,5-trisphosphate receptor. J. Biol. Chem. 272, 2675-2681 (1997).
24. 3 receptors: Some lessons from DT40 cells. Immunol. Rev. 231, 23-44 (2009).
25. H. Sugawara, M. Kurosaki, M. Takata, T. Kurosaki, Genetic evidence for involvement of type 1, type 2 and type 3 inositol 1,4,5-trisphosphate receptors in signal transduction through the B-cell antigen receptor. EMBO J. 16, 3078-3088 (1997).
26. F. Yoshikawa, M. Morita, T. Monkawa, T. Michikawa, T. Furuichi, K. Mikoshiba, Mutational analysis of the ligand binding site of the inositol 1,4,5-trisphosphate receptor. J. Biol. Chem. 271, 18277-18284 (1996).
27. 2+ in triggering inositol 1,4,5-trisphosphate receptor ubiquitination. Biochem. J. 392, 601-606 (2005).
28. A. Šali, T. L. Blundell, Comparative protein modelling by satisfaction of spatial restraints. J. Mol. Biol. 234, 779-815 (1993).
29. F. A. Ran, P. D. Hsu, J. Wright, V. Agarwala, D. A. Scott, F. Zhang, Genome engineering using the CRISPR-Cas9 system. Nat. Protoc. 8, 2281-2308 (2013).
30. S. K. Joseph, S. Bokkala, D. Boehning, S. Zeigler, Factors determining the composition of inositol trisphosphate receptor hetero-oligomers expressed in COS cells. J. Biol. Chem. 275, 16084-16090 (2000).
31. K. J. Alzayady, L. E. Wagner II, R. Chandrasekhar, A. Monteagudo, R. Godiska, G.G. Tall, S. K. Joseph, D. I. Yule, Functional inositol 1,4,5-trisphosphate receptors assembled from concatenated homo- and heteromeric subunits. J. Biol. Chem. 288, 29772-29784 (2013).
32. R. Chandrasekhar, K. J. Alzayady, L. E. Wagner II, D. I. Yule, Unique regulatory properties of heterotetrameric inositol 1,4,5-trisphosphate receptors revealed by studying concatenated receptor constructs. J. Biol. Chem. 291, 4846-4860 (2016).
33. 2+ and ATP. J. Physiol. 590, 3245-3259 (2012).
34. J. Chan, H. Yamazaki, N. Ishiyama, M.-D. Seo, T. K. Mal, T. Michikawa, K. Mikoshiba, M. Ikura, Structural studies of inositol 1,4,5-trisphosphate receptor: Coupling ligand binding to channel gating. J. Biol. Chem. 285, 36092-36099 (2010).
35. Z. T. Schug, S. K. Joseph, The role of the S4-S5 linker and C-terminal tail in inositol 1,4,5-trisphosphate receptor function. J. Biol. Chem. 281, 24431-24440 (2006).
36. S. K. Joseph, Role of thiols in the structure and function of inositol trisphosphate receptors. Curr. Top. Membr. 66, 299-322 (2010).
37. D. I. Yule, S. A. Ernst, H. Ohnishi, R. J. Wojcikiewicz, Evidence that zymogen granules are not a physiologically relevant calcium pool. Defining the distribution of inositol 1,4,5-trisphosphate receptors in pancreatic acinar cells. J. Biol. Chem. 272, 9093-9098 (1997).
38. C. U. Choe, B. E. Ehrlich, The inositol 1,4,5-trisphosphate receptor (IP3R) and its regulators: Sometimes good and sometimes bad teamwork. Sci. STKE 2006, re15 (2006).
39. 3) receptors by reactive oxygen species. J. Biol. Chem. 289, 8170-8181 (2014).
40. 2+ release channels. J. Biol. Chem. 288, 11122-11134 (2013).
41. 2+ release by type-2 and type-3 inositol (1,4,5)-triphosphate receptors. Differing ATP sensitivities and molecular determinants of action. J. Biol. Chem. 283, 21579-21587 (2008).
42. E. F. Pettersen, T. D. Goddard, C. C. Huang, G. S. Couch, D. M. Greenblatt, E. C. Meng, T. E. Ferrin, UCSF Chimera-A visualization system for exploratory research and analysis. J. Comput. Chem. 25, 1605-1612 (2004).